Commercial Pet Cloning Substrate (Mortality-Anxiety Conversion, Companion-Animal Layer)
Idea
A 30-year commercial pet-cloning industry (companies in Seoul, Texas, and Beijing; a market of $319M in 2025 projected to reach $3.58B by 2035) operating outside Western academic ethics moratoria. It matters here as an example of the gap between public perception and reality: people treat pet cloning as a fringe novelty while it is in fact an industrialized genetic-replication business, and it converts grief over mortality into revenue.
The engine's definition — word for word
30-year continuous commercial substrate operating outside Western academic ethical moratoria. Sooam (Seoul, 2006-, 1,000+ dogs), ViaGen Pets (Texas, 2015-, 600 dogs + 400 cats), Sinogene (Beijing, 2017-, 500+ clones + 1,000-beagle surrogate base). Market $319M (2025) → projected $3.58B (2035) at 30.9% CAGR. Engine framing: cap-table-adjacent mortality-anxiety conversion mechanism (same logic as Longevity Industrial Complex applied to companion-animal layer). Demonstrates that Substrate-vs-Announcement divergence operates not only at geopolitical / financial / regulatory layers but also at consumer-veterinary commerce layer — public perception treats pet cloning as fringe novelty while market reality is industrialized elite-genetic-replication assembly line.
Walk this on the live map →